Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 1 Schemes (0.15%)
Foreign Institutions
Held by 85 Foreign Institutions (10.0%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
145 Million
(Quarterly Results - Dec 2025)
Net Profit:
12 Million
Pharmaceuticals & Biotechnology
ILS 1,487 Million ()
17.00
NA
0.03%
-0.27
9.02%
1.73






